SilverCross’ Post

https://lnkd.in/gmBj7UvK Join us for our next webinar on May 22! We’re excited to tap into the Healthcare and Pharma industries to discover insights into patient communities, how pharmaceuticals are landing and their side effects, and more. #InfegyInsights #Healthcare #Pharma #SocialListening

Join us for our next webinar on May 22! We’re excited to tap into the Healthcare and Pharma industries to discover insights into patient communities, how pharmaceuticals are landing and their side effects, and more. #InfegyInsights #Healthcare #Pharma #SocialListening

An insightful look at trends in life sciences for 2024 from Pharmaceutical Executive Magazine, including key trends, how leaders today can build resilient companies; and AI’s relevance in healthcare. https://bit.ly/43uZsaH #lifesciences

"Exciting times ahead for the pharmaceutical sector! From personalized medicine to digital health innovations, here are the top trends shaping the future of healthcare. Check out the below video" #pharmaceuticalindustry #healthcareinnovations #campusconnect #elearning #trends #innovation

🔬 Unlock the power of real-world data to enhance patient outcomes in the pharmaceutical industry. Our latest market insights provide actionable tips and strategies that pharma companies can implement for better healthcare solutions. Dive into these valuable insights and discover how to leverage data to make informed decisions and improve patient care. 🌐 Learn more: www.grgonline.com #Pharma #RealWorldData #PatientOutcomes #HealthcareInnovation #GRGInsights #PharmaTrends #DataDrivenHealthcare

Addressing diversity gaps in #clinicaltrials is crucial for equitable #healthcare outcomes. While recent government guidance is a step forward, pharmaceutical companies must take proactive steps now. Our CEO Ariel Katz predicts three factors that will fuel a massive transformation in clinical trial diversity in his article for Society for Clinical Research Sites (SCRS): https://hubs.la/Q02kRZ_Q0 #clinicaltrials #diversity #pharma

While healthcare has the potential to function as an essential pillar of the #nexteconomy, it’s no secret that the current US healthcare system is dysfunctional. 🤕 In this episode of #NextEconomyNow we are joined by Dana Brown, a leading expert in public-sector pharmaceutical production, to imagine a non-extractive system of healthcare that prioritizes the health and wellbeing of people over profits. 🩺 Listen ➡️ https://lnkd.in/g5DxDkAb

"Good morning to all our fellow pharmaceutical companies! As we embark on a new day in the pursuit of health and well-being, let's continue to collaborate, innovate, and drive positive change in the healthcare industry. Together, we're not just developing medications, but shaping a healthier future for all. Wishing you a productive and impactful day ahead! #PharmaCommunity #HealthcareLeaders #GoodMorning"

Addressing diversity gaps in #clinicaltrials is crucial for equitable #healthcare outcomes. While recent government guidance is a step forward, pharmaceutical companies must take proactive steps now. Our CEO Ariel Katz predicts three factors that will fuel a massive transformation in clinical trial diversity in his article for Society for Clinical Research Sites (SCRS): https://hubs.la/Q02kbGDN0 #ClinicalTrials #Diversity #Pharma

I’m happy to share my insights on the evolving specialty pharmaceutical landscape featured in the May issue of Healthcare Tech Outlook. As groundbreaking treatments and novel therapies are continuously being approved, there are a multitude of challenges encountered by industry stakeholders. Learn more about how AscellaHealth's proactive approach drives success for clients and enhances outcomes for patients. Read more here: https://lnkd.in/eG9NHSrM #AscellaHealth #lifesciences #technology #specialtypharmacy